← Back to Search

Resistance Exercise

Resistance Exercise for Prediabetes (PEAR Trial)

N/A
Waitlist Available
Led By Tanya M Halliday, PhD, RD
Research Sponsored by University of Utah
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline: pre-meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / post-intervention(week 4) :pre-meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
Awards & highlights

PEAR Trial Summary

This study is evaluating whether different types of exercise influence appetite regulation.

Eligible Conditions
  • Prediabetes
  • Compulsive Eating

PEAR Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline: pre-meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / post-intervention(week 4) :pre-meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline: pre-meal , 30 minutes, 60 minutes, 90 minutes, and 120 minutes post meal / post-intervention(week 4) :pre-meal, 30 minutes, 60 minutes, 90 minutes ,and 120 minutes post meal for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Changes in Appetite Rating
Changes in Hormonal Response to Feeding
Secondary outcome measures
Change in Ad libitum Energy Intake - In lab
Changes in Ad libitum Energy Intake - Free Living
Changes in Body Composition
+3 more

PEAR Trial Design

1Treatment groups
Experimental Treatment
Group I: Resistance ExerciseExperimental Treatment1 Intervention
Resistance exercise will be training all major muscle groups 2x/week (2 days upper body, 2 days lower body) at 40-50% 1 repetition max (RM; estimated from 10 RM baseline testing) for 3 sets of 10-12 reps. This equals 4x/week for the 3 week intervention period.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Resistance Exercise
2017
Completed Phase 4
~880

Find a Location

Who is running the clinical trial?

University of UtahLead Sponsor
1,099 Previous Clinical Trials
1,778,666 Total Patients Enrolled
Tanya M Halliday, PhD, RDPrincipal InvestigatorUniversity of Utah
1 Previous Clinical Trials
38 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~4 spots leftby Apr 2025